Related Experiment Video
Updated: Jun 22, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
RUNX3 has an oncogenic role in head and neck cancer
Takaaki Tsunematsu1, Yasusei Kudo, Shinji Iizuka
1Division of Frontier Medical Science, Department of Oral and Maxillofacial Pathobiology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Background:
Runt-related transcription factor 3 (RUNX3) is a tumor suppressor of cancer and appears to be an important component of the transforming growth factor-beta (TGF-ss)-induced tumor suppression pathway. Surprisingly, we found that RUNX3 expression level in head and neck squamous cell carcinoma (HNSCC) tissues, which is one of the most common types of human cancer, was higher than that in normal tissues by a previously published microarray dataset in our preliminary study. Therefore, here we examined the oncogenic role of RUNX3 in HNSCC.
Principal Findings:
Frequent RUNX3 expression and its correlation with malignant behavior were observed in HNSCC. Ectopic RUNX3 overexpression promoted cell growth and inhibited serum starvation-induced apoptosis and chemotherapeutic drug induced apoptosis in HNSCC cells. These findings were confirmed by RUNX3 knockdown. Moreover, RUNX3 overexpression enhanced tumorsphere formation. RUNX3 expression level was well correlated with the methylation status in HNSCC cells. Moreover, RUNX3 expression was low due to the methylation of its promoter in normal oral epithelial cells.
Conclusions/Significance:
Our findings suggest that i) RUNX3 has an oncogenic role in HNSCC, ii) RUNX3 expression observed in HNSCC may be caused in part by demethylation during cancer development, and iii) RUNX3 expression can be a useful marker for predicting malignant behavior and the effect of chemotherapeutic drugs in HNSCC.
Insights
Runt-related transcription factor 3 (RUNX3) surprisingly acts as an oncogene in head and neck squamous cell carcinoma (HNSCC), promoting cancer growth and resistance to apoptosis. RUNX3 may serve as a marker for HNSCC malignancy and drug response.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Runt-related transcription factor 3 (RUNX3) is typically a tumor suppressor.
- RUNX3 is involved in the transforming growth factor-beta (TGF-β) tumor suppression pathway.
- Preliminary data indicated higher RUNX3 expression in head and neck squamous cell carcinoma (HNSCC) than normal tissues.
Purpose of the Study:
- To investigate the role of RUNX3 in HNSCC.
- To determine if RUNX3 has an oncogenic function in HNSCC.
Main Methods:
- Analysis of RUNX3 expression in HNSCC tissues.
- Experimental manipulation of RUNX3 levels (overexpression and knockdown) in HNSCC cells.
- Assessment of cell growth, apoptosis, and tumorsphere formation.
- Correlation analysis with methylation status.
Main Results:
- RUNX3 was frequently expressed in HNSCC and correlated with malignant behavior.
- RUNX3 overexpression promoted HNSCC cell growth and inhibited apoptosis.
- RUNX3 knockdown reversed these effects.
- RUNX3 overexpression enhanced tumorsphere formation.
- RUNX3 expression correlated with promoter methylation status; low RUNX3 in normal cells was linked to promoter methylation.
Conclusions:
- RUNX3 exhibits an oncogenic role in HNSCC.
- Demethylation may contribute to RUNX3 upregulation in HNSCC.
- RUNX3 expression can predict HNSCC malignancy and response to chemotherapy.
More Related Videos
07:00Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Ras Gene
Ras is a superfamily...
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...